This study presents a cohort of individuals with heterozygous damaging variants in EIF3A and EIF3B, exhibiting a heterogeneous clinical phenotype primarily characterized by craniofacial abnormalities, CHD (most commonly TOF), and mild neurodevelopmental features. The gene discussed is EIF3B; the disease is coronary artery disorder.